PROPRIETARY Cannabinoid PROCESS
Our team has decades of scientific, API production and quality control, and has produced thousands of oral solution products and kilograms of cannabinoid products for multiple clinical trials.
Today, we are the only cannabinoid active pharmaceutical ingredient (API) contract manufacturing site in the U.S. producing an FDA approved Dronabinol Oral Solution drug (SYNDROS®). Our biomimetic natural product derived process enables us to produce cannabinoids in a cGMP controlled environment. This proprietary process allows us to access rare cannabinoids, including their free-acid and varin (C3) forms, by replicating the elegance and efficiency that nature employs when constructing cannabinoid molecules.